Myomo
MYO· Manufacturing· Fiscal year ends in December
CEO pay in FY2024
Paul R. Gudonis is the CEO of Myomo and was paid $1.2M in FY2024 (Dec), up 87%.
PayNo stock prices for these years
Executives3
See all- 1Paul R. GudonisChief Executive OfficerFY2024
- 2David A. HenryChief Financial OfficerFY2024
- 3Harry KovelmanChief Medical OfficerFY2024
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allMyomo paid its 3 named executives $2.7M in total in FY2024 (Dec). CEO Paul R. Gudonis was paid $1.2M of that.
| Name | |||
|---|---|---|---|
| Paul R. GudonisChief Executive Officer | |||
| David A. HenryChief Financial Officer | |||
| Harry KovelmanChief Medical Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Myomo. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board3
See all- Thomas F. KirkLead independent director · 11 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance (Chair), Technology, Quality and Regulatory—Paid as an executive
- Joseph M. Manko, Jr.Director · -1 yr on the boardIndependent—Paid as an executive
- William J. FebboDirector · -1 yr on the boardIndependent—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | May 14, 2026 | FY2025 |
| Annual report | 10-K | Mar 9, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 25, 2025 | FY2024 |
| Annual report | 10-K | Mar 10, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Mar 8, 2024 | FY2023 |
